ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,646 | -15.4% | 1,257,195 | -0.8% | 0.55% | -16.9% |
| Q1 2023 | $45,680 | -25.2% | 1,267,830 | -18.0% | 0.67% | -23.2% |
| Q4 2022 | $61,100 | -99.9% | 1,546,060 | -1.2% | 0.87% | -0.6% |
| Q3 2022 | $62,878,000 | -7.0% | 1,564,900 | -2.7% | 0.87% | -7.2% |
| Q2 2022 | $67,592,000 | +5.1% | 1,607,800 | -2.6% | 0.94% | +30.7% |
| Q1 2022 | $64,319,000 | -2.4% | 1,650,900 | -0.2% | 0.72% | +23.5% |
| Q4 2021 | $65,888,000 | +19.9% | 1,653,400 | +8.8% | 0.58% | +21.9% |
| Q3 2021 | $54,933,000 | -10.7% | 1,520,000 | +1.2% | 0.48% | -4.8% |
| Q2 2021 | $61,549,000 | -0.3% | 1,501,560 | +6.1% | 0.50% | -4.9% |
| Q1 2021 | $61,749,000 | -23.2% | 1,415,615 | -11.9% | 0.53% | -19.0% |
| Q4 2020 | $80,454,000 | +93.5% | 1,607,480 | +62.6% | 0.65% | +67.9% |
| Q3 2020 | $41,587,000 | +14.1% | 988,510 | +31.7% | 0.39% | +11.8% |
| Q2 2020 | $36,451,000 | – | 750,800 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |